Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure

Stephen J D O'Keefe, Palle B Jeppesen, Richard Gilroy, Marek Pertkiewicz, Johane P Allard, Bernard Messing

    149 Citationer (Scopus)

    Abstract

    Although home parenteral nutrition (PN) can save the lives of patients with massive bowel loss that results in short-bowel syndrome and intestinal failure, quality of life is impaired by PN and its complications. We examined the 12-month tolerability and efficacy of teduglutide to reduce PN dependency.
    OriginalsprogEngelsk
    TidsskriftClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
    Vol/bind11
    Udgave nummer7
    Sider (fra-til)815-23.e1-3
    ISSN1542-3565
    DOI
    StatusUdgivet - jul. 2013

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure'. Sammen danner de et unikt fingeraftryk.

    Citationsformater